[The epidermolysis syndrome (Lyell) from the viewpoint of internal medicine].
D000208:Acute Disease; D000368:Aged; D000804:Angiotensin II / Q000008:administration & dosage / Q000627:therapeutic use; D006332:Cardiomegaly / Q000150:complications; D002761:Cholangitis / Q000150:complications; D002908:Chronic Disease; D048909:Diabetes Complications; D005921:Glomerulonephritis / Q000150:complications; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications; D008297:Male; D008712:Methicillin / Q000627:therapeutic use*; D008875:Middle Aged; D010182:Pancreatic Diseases / Q000150:complications; D011188:Potassium / Q000627:therapeutic use; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D011379:Prognosis; D013262:Stevens-Johnson Syndrome / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy
D000804:Angiotensin II; D011239:Prednisolone; D008712:Methicillin; D011188:Potassium
Internistische Aspekte des Epidermolyse-Syndromes (Lyell.